On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
暂无分享,去创建一个
S. Bhakdi | E. Wieland | J. Torzewski | I. Walev | B. Dorweiler | Eric Weise | Jorgen Tranumjensen | Roger Kirchmann
[1] H. Lodish,et al. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. , 1994, The Journal of biological chemistry.
[2] G. Anantharamaiah,et al. Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[3] M. Nieminen,et al. Infection and inflammation as risk factors for myocardial infarction. , 1993, European heart journal.
[4] D. Steinberg,et al. Peroxidase-dependent metal-independent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation? , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] L. Stanton,et al. CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.
[6] M. Cybulsky,et al. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.
[7] M. Territo,et al. Cellular Interactions of the Arterial Wall , 1992 .
[8] U. Steinbrecher,et al. Modified low-density lipoproteins : diversity and biological relevance in atherogenesis , 1992 .
[9] U. Steinbrecher,et al. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[10] V. Tertov,et al. Hydrolysis of cholesteryl ester in low density lipoprotein converts this lipoprotein to a liposome. , 1992, Journal of Biological Chemistry.
[11] F. Wolber,et al. A simple method for the purification of human peripheral blood monocytes. A substitute for Sepracell-MN. , 1991, Journal of immunological methods.
[12] M. Mims,et al. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. , 1991, Journal of lipid research.
[13] Y. Marcel,et al. Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy. , 1991, The Journal of biological chemistry.
[14] V. Tertov,et al. Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency. , 1991, Atherosclerosis.
[15] N. Simionescu,et al. Purification and partial characterization of extracellular liposomes isolated from the hyperlipidemic rabbit aorta. , 1990, Journal of lipid research.
[16] S. Bhakdi,et al. Isolation and characterization of a complement-activating lipid extracted from human atherosclerotic lesions , 1990, The Journal of experimental medicine.
[17] U. Steinbrecher,et al. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. , 1990, Journal of lipid research.
[18] A. J. Valente,et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[19] S. Bhakdi,et al. [Functions and relevance of the terminal complement sequence]. , 1990, Immunitat und Infektion.
[20] M. Territo,et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. , 1990, The Journal of clinical investigation.
[21] A. Fogelman,et al. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. , 1989, Journal of lipid research.
[22] G. Hansson,et al. Prelesional complement activation in experimental atherosclerosis. Terminal C5b-9 complement deposition coincides with cholesterol accumulation in the aortic intima of hypercholesterolemic rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[23] H. Esterbauer,et al. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. , 1989, Journal of lipid research.
[24] A. Chait,et al. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Steinberg,et al. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. , 1989, The Journal of biological chemistry.
[26] J. Resau,et al. Unesterified cholesterol-rich lipid particles in atherosclerotic lesions of human and rabbit aortas. , 1988, The American journal of pathology.
[27] S. Bhakdi,et al. Sensitive ELISA for quantitating the terminal membrane C5b-9 and fluid-phase SC5b-9 complex of human complement. , 1987, Journal of immunological methods.
[28] N. Simionescu,et al. Prelesional events in atherogenesis. Accumulation of extracellular cholesterol-rich liposomes in the arterial intima and cardiac valves of the hyperlipidemic rabbit. , 1986, The American journal of pathology.
[29] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[30] H. Kruth. Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development. , 1985, Atherosclerosis.
[31] H. Rus,et al. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque. , 1985, Atherosclerosis.
[32] V. Armstrong,et al. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). , 1985, Journal of lipid research.
[33] D. Morel,et al. Monocytes and Neutrophils Oxidize Low Density Lipoprotein Making It Cytotoxic , 1985, Journal of leukocyte biology.
[34] S. Fowler,et al. Nile red: a selective fluorescent stain for intracellular lipid droplets , 1985, The Journal of cell biology.
[35] S. Bhakdi,et al. A simple method for quantitative measurement of C3d in human plasma. , 1984, Journal of immunological methods.
[36] J L Witztum,et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[37] Kruth Hs. Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles , 1984 .
[38] D. Steinberg,et al. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Brown,et al. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. , 1980, The Journal of biological chemistry.
[40] P. Edwards,et al. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[41] A. Motulsky,et al. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. , 1973, The Journal of clinical investigation.
[42] D. B. Zilversmit,et al. Quantitative aspects of cholesterol flux in rabbit atheromatous lesions. , 1962, The Journal of biological chemistry.
[43] R. Havel,et al. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.
[44] P. Schuff-Werner,et al. Plasma lipids are not oxidized during hemodialysis. , 1994, Nephron.
[45] M. Krieger,et al. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.
[46] V. Armstrong,et al. Oxidative Modification of Low Density Lipoproteins by Human Polymorphonuclear Leukocytes , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[47] H. Hoff,et al. Macrophage uptake of cholesterol-containing particles derived from LDL and isolated from atherosclerotic lesions. , 1990, European heart journal.
[48] J. Tranum-Jensen. Electron microscopy: assays involving negative staining. , 1988, Methods in enzymology.
[49] H. Kruth,et al. Localization of unesterified cholesterol in human atherosclerotic lesions. Demonstration of filipin-positive, oil-red-O-negative particles. , 1984, The American journal of pathology.
[50] M. Kazatchkine,et al. The Human Alternative Complement Pathway : Biology and Immunopathology of Activation and Regulation1 , 1982 .
[51] M. Brown,et al. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Brown,et al. The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.